Centiva Capital, LP Roivant Sciences Ltd. Transaction History

Centiva Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $1.34 Million - $1.52 Million	-129,763 Reduced 81.2%	30,034 $317,000
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $1.53 Million - $1.82 Million	154,538 Added 2938.54%	159,797 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$8.38 - $11.58 $374,711 - $517,799	-44,715 Reduced 89.48%	5,259 $59,000
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $487,746 - $659,157	49,974 New	49,974 $583,000
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $178,278 - $1.69 Million	-349,566 Reduced 69.19%	155,624 $501,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $384,110 - $661,598	136,694 Added 37.1%	505,190 $2.06 Million
Q1 2022 May 16, 2022	BUY	$4.74 - $9.91 $1.75 Million - $3.65 Million	368,496 New	368,496 $1.82 Million

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.95B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.